Physician profile
Steven L Mack
NPI 1578550091
$1,073.84
in general payments reported to CMS, 2019-2025
19 companies · $67.66 in 2025
The $67.66 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $149 · 2023: $276 · 2024: $238 · 2025: $67.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $355.19 | 2021-2024 | Myrbetriq |
| Procept Biorobotics Corporation | $84.67 | 2024 | Aquabeam System |
| Pfizer INC. | $83.27 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $81.53 | 2021-2023 | Oxlumo |
| Janssen Biotech, INC. | $64.85 | 2024 | Erleada |
| Axonics, INC. | $50.78 | 2022-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $48.98 | 2022-2025 | Obtryx System - Curved |
| Antares Pharma, INC. | $36.86 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $36.03 | 2021 | |
| Dendreon Pharmaceuticals LLC | $34.81 | 2023 | Provenge |
| Myovant Sciences INC. | $27.05 | 2021 | |
| Sumitomo Pharma America, INC. | $25.50 | 2025 | Gemtesa |
| Urovant Sciences INC | $24.82 | 2021 | |
| Teleflex LLC | $24.67 | 2023 | Urolift |
| Abbvie INC. | $24.14 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $21.37 | 2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $19.45 | 2021 | |
| Laborie Medical Technologies Corp. | $16.97 | 2023 | |
| 180 Medical, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.